"Cost-Benefit Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.
Descriptor ID |
D003362
|
MeSH Number(s) |
N03.219.151.125
|
Concept/Terms |
Cost-Benefit Analysis- Cost-Benefit Analysis
- Analyses, Cost-Benefit
- Analysis, Cost-Benefit
- Cost-Benefit Analyses
- Cost Benefit Analysis
- Analyses, Cost Benefit
- Analysis, Cost Benefit
- Cost Benefit Analyses
Cost-Utility Analysis- Cost-Utility Analysis
- Analyses, Cost-Utility
- Analysis, Cost-Utility
- Cost Utility Analysis
- Cost-Utility Analyses
Economic Evaluation- Economic Evaluation
- Economic Evaluations
- Evaluation, Economic
- Evaluations, Economic
Marginal Analysis- Marginal Analysis
- Analyses, Marginal
- Analysis, Marginal
- Marginal Analyses
Cost Benefit- Cost Benefit
- Costs and Benefits
- Benefits and Costs
|
Below are MeSH descriptors whose meaning is more general than "Cost-Benefit Analysis".
Below are MeSH descriptors whose meaning is more specific than "Cost-Benefit Analysis".
This graph shows the total number of publications written about "Cost-Benefit Analysis" by people in this website by year, and whether "Cost-Benefit Analysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 0 | 1 | 1 |
1997 | 0 | 5 | 5 |
1998 | 0 | 9 | 9 |
1999 | 0 | 5 | 5 |
2000 | 0 | 3 | 3 |
2001 | 0 | 10 | 10 |
2002 | 0 | 7 | 7 |
2003 | 0 | 5 | 5 |
2004 | 1 | 4 | 5 |
2005 | 2 | 9 | 11 |
2006 | 1 | 7 | 8 |
2007 | 1 | 9 | 10 |
2008 | 1 | 8 | 9 |
2009 | 0 | 9 | 9 |
2010 | 0 | 7 | 7 |
2011 | 0 | 10 | 10 |
2012 | 0 | 13 | 13 |
2013 | 0 | 8 | 8 |
2014 | 0 | 6 | 6 |
2015 | 0 | 6 | 6 |
2016 | 1 | 7 | 8 |
2017 | 2 | 9 | 11 |
2018 | 2 | 3 | 5 |
2019 | 2 | 6 | 8 |
2020 | 1 | 3 | 4 |
2021 | 1 | 0 | 1 |
2022 | 0 | 3 | 3 |
2023 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cost-Benefit Analysis" by people in Profiles.
-
Cost-effectiveness of a 3-year tele-messaging intervention for positive airway pressure use. Am J Manag Care. 2023 05; 29(5):256-263.
-
Comparing the clinical and cost-effectiveness of remote (telehealth and online) cognitive behavioral therapy-based treatments for high-impact chronic pain relative to usual care: study protocol for the RESOLVE multisite randomized control trial. Trials. 2023 Mar 16; 24(1):196.
-
Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening. JAMA Netw Open. 2023 03 01; 6(3):e234052.
-
Cost-Effectiveness of Motivational Interviewing to Reduce Alcohol and Cannabis Use Among Patients With Depression. J Stud Alcohol Drugs. 2022 09; 83(5):662-671.
-
Costs and Cost-Effectiveness of Implementing a Digital Diabetes Prevention Program in a Large, Integrated Health System. Perm J. 2022 09 14; 26(3):74-82.
-
Health effects and cost-effectiveness of a multilevel physical activity intervention in low-income older adults; results from the PEP4PA cluster randomized controlled trial. Int J Behav Nutr Phys Act. 2022 Jun 27; 19(1):75.
-
Cost-effectiveness of Brief Behavioral Therapy for Pediatric Anxiety and Depression in Primary Care. JAMA Netw Open. 2021 03 01; 4(3):e211778.
-
Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact model. J Manag Care Spec Pharm. 2020 Dec; 26(12):1567-1575.
-
Postoperative Opioid Analgesia Impacts Resource Utilization in Infants Undergoing Pyloromyotomy. J Surg Res. 2020 11; 255:594-601.
-
Authors' response: Cost-effectiveness evidence for HPV self-sampling could be improved by giving greater attention to vulnerable populations. Prev Med. 2020 10; 139:106081.